1:17-cv-01163 | Bayer Intellectual Property GmbH et al v. Torrent Pharmaceuticals, Limited et al | Aug 18, 2017 |
1:17-cv-01164 | Teva Pharmaceuticals International GmbH et al v. Apotex Inc. et al | Aug 18, 2017 |
1:17-cv-01201 | Teva Pharmaceuticals International GmbH et al v. Fresenius Kabi USA, LLC | Aug 24, 2017 |
1:17-cv-01790 | Teva Pharmaceuticals International GmbH et al v. Mylan Laboratories Limited | Dec 12, 2017 |
1:18-cv-00117 | Teva Pharmaceuticals International GmbH et al v. Slayback Pharma Limited Liability Company | Jan 19, 2018 |
1:18-cv-01074 | Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. | Jul 19, 2018 |
1:18-cv-01459 | Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC | Sep 20, 2018 |
1:18-cv-01586 | Teva Pharmaceuticals International GmbH et al v. Fresenius Kabi USA, LLC et al | Oct 15, 2018 |
1:18-cv-01953 | Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC | Dec 11, 2018 |
1:19-cv-01251 | Teva Pharmaceuticals International GmbH et al v. Lupin, Ltd. et al | Jul 2, 2019 |
1:19-cv-01251 | TAIHO PHARMACEUTICAL CO., LTD et al v. ACCORD HEALTHCARE INC. et al | Dec 23, 2019 |
1:20-cv-00632 | Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al | May 11, 2020 |
1:21-cv-00952 | Teva Pharmaceuticals International GmbH et al v. Accord Healthcare Inc. | Jun 29, 2021 |
1:21-cv-01256 | Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC et al | Aug 31, 2021 |
1:21-cv-01619 | Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. | Nov 16, 2021 |
1:22-cv-00042 | Eagle Pharmaceuticals, Inc. v. Celerity Pharmaceuticals, LLC, et al., | Jan 11, 2022 |
1:22-cv-00143 | ARBOR PHARMACEUTICALS, LLC v. ALKEM LABORATORIES LTD. | Jan 11, 2022 |
1:22-cv-00704 | Eagle Pharmaceuticals, Inc. v. Accord Healthcare Inc. et al | May 27, 2022 |
1:23-cv-00490 | Teva Pharmaceuticals International GmbH et al v. BendaRx USA | May 4, 2023 |
1:23-cv-00788 | Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp | Jun 16, 2023 |
1:24-cv-00395 | Maximus, Inc. v. Holdren | Mar 12, 2024 |
1:24-cv-00395 | Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp | Mar 28, 2024 |